Merck & Co., Inc. (MRK) operating KPIs
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)
Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%
Merck external Manufacturing — EHS Assessments of Prospective Suppliers (count)
Merck Impact Report
Latest, FY2025
45
Period ended Dec 31, 2025
Change on a year earlier
-4.3%
47 in FY2024
History
8 years
Since FY2018
Sources
1
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | External Manufacturing — EHS Assessments of Prospective Suppliers (count) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 45 | -4.3% | – |
| FY2024 | Dec 31, 2024 | 47 | -4.1% | – |
| FY2023 | Dec 31, 2023 | 49 | +81.5% | – |
| FY2022 | Dec 31, 2022 | 27 | -35.7% | – |
| FY2021 | Dec 31, 2021 | 42 | -16.0% | – |
| FY2020 | Dec 31, 2020 | 50 | +16.3% | – |
| FY2019 | Dec 31, 2019 | 43 | -33.8% | – |
| FY2018 | Dec 31, 2018 | 65 | – | – |
Cite this data
StockData. (2026). Merck External Manufacturing — EHS Assessments of Prospective Suppliers (count), annual FY2018–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/esg_ehs_prosp
See every metric in the Merck KPI table. Data updated Oct 26, 2026.